Simulations Plus (NASDAQ:SLP) Price Target Raised to $37.00 at KeyCorp

Simulations Plus (NASDAQ:SLP) had its target price hoisted by stock analysts at KeyCorp from $35.00 to $37.00 in a research report issued on Friday,Benzinga reports. The firm currently has an “overweight” rating on the technology company’s stock. KeyCorp’s target price suggests a potential upside of 9.53% from the company’s current price.

Several other equities research analysts also recently commented on the company. BTIG Research decreased their price objective on Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a report on Thursday, October 24th. Stephens started coverage on shares of Simulations Plus in a research report on Friday, November 15th. They set an “overweight” rating and a $39.00 target price for the company. William Blair reiterated an “outperform” rating on shares of Simulations Plus in a research note on Wednesday, January 8th. Finally, StockNews.com lowered Simulations Plus from a “hold” rating to a “sell” rating in a report on Monday, November 4th. One analyst has rated the stock with a sell rating, one has issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $49.40.

Simulations Plus Stock Performance

Shares of SLP stock opened at $33.78 on Friday. The company has a market cap of $678.64 million, a P/E ratio of 84.45 and a beta of 0.80. Simulations Plus has a fifty-two week low of $24.00 and a fifty-two week high of $51.22. The stock has a 50 day simple moving average of $29.95 and a two-hundred day simple moving average of $32.84.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings data on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.02. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The firm had revenue of $18.70 million for the quarter, compared to analyst estimates of $19.73 million. During the same quarter in the prior year, the business earned $0.18 earnings per share. The business’s quarterly revenue was up 19.9% compared to the same quarter last year. On average, research analysts predict that Simulations Plus will post 1.09 earnings per share for the current year.

Insider Buying and Selling

In related news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction dated Friday, November 1st. The stock was sold at an average price of $27.66, for a total value of $553,200.00. Following the completion of the sale, the director now owns 3,462,584 shares of the company’s stock, valued at approximately $95,775,073.44. This trade represents a 0.57 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 19.40% of the stock is owned by insiders.

Institutional Trading of Simulations Plus

Several hedge funds and other institutional investors have recently modified their holdings of the business. Conestoga Capital Advisors LLC lifted its position in shares of Simulations Plus by 15.0% during the fourth quarter. Conestoga Capital Advisors LLC now owns 2,226,262 shares of the technology company’s stock worth $62,090,000 after acquiring an additional 290,414 shares in the last quarter. Cook Wealth LLC lifted its holdings in shares of Simulations Plus by 19.1% in the fourth quarter. Cook Wealth LLC now owns 12,386 shares of the technology company’s stock worth $345,000 after buying an additional 1,984 shares in the last quarter. Tributary Capital Management LLC boosted its position in shares of Simulations Plus by 21.7% in the fourth quarter. Tributary Capital Management LLC now owns 396,093 shares of the technology company’s stock valued at $11,047,000 after acquiring an additional 70,526 shares during the period. JPMorgan Chase & Co. grew its stake in Simulations Plus by 106.0% during the third quarter. JPMorgan Chase & Co. now owns 47,365 shares of the technology company’s stock valued at $1,517,000 after acquiring an additional 24,371 shares in the last quarter. Finally, Principal Financial Group Inc. grew its position in shares of Simulations Plus by 2.6% during the 3rd quarter. Principal Financial Group Inc. now owns 87,273 shares of the technology company’s stock valued at $2,794,000 after purchasing an additional 2,226 shares in the last quarter. Institutional investors own 78.08% of the company’s stock.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.